SBC Medical Group Holdings (SBCWW) Cost of Revenue (2023 - 2025)

SBC Medical Group Holdings has reported Cost of Revenue for 3 years, with the latest figure at $10.6 million in Q4 2025.

• For the quarter ending Q4 2025, Cost of Revenue rose 0.85% year-over-year to $10.6 million; the trailing twelve-month figure through Dec 2025 stood at $46.3 million (down 6.16% YoY), and the FY2025 full-year result was $46.3 million, down 6.16% from the prior year.
• Cost of Revenue for Q4 2025 stood at $10.6 million, down from $12.7 million in the prior quarter.
• The five-year high for Cost of Revenue was $19.0 million in Q4 2023, with the low at $9.6 million in Q1 2025.
• Historically, Cost of Revenue has averaged $12.8 million across 3 years, with a median of $13.0 million in 2025.
• Annual changes were most pronounced in 2024 — Cost of Revenue sank 44.43% — and 2025, when it rose 29.41%.
• SBC Medical Group Holdings' Cost of Revenue stood at $19.0 million in 2023, then slumped by 44.43% to $10.5 million in 2024, then climbed by 0.85% to $10.6 million in 2025.
• The last three Cost of Revenue figures came in at $10.6 million (Q4 2025), $12.7 million (Q3 2025), and $13.3 million (Q2 2025), per Business Quant data.